InnoCan Pharma Corporation
INNO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.83M | -2.60M | -4.34M | -5.20M | -4.70M |
| Total Depreciation and Amortization | 35.00K | 37.00K | 37.00K | 36.00K | 33.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.42M | 1.72M | 2.70M | 2.85M | 1.56M |
| Change in Net Operating Assets | -1.20M | -1.54M | -499.00K | -1.18M | -793.00K |
| Cash from Operations | -1.58M | -2.39M | -2.10M | -3.49M | -3.90M |
| Capital Expenditure | -15.00K | -20.00K | -14.00K | -21.00K | -46.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.00K | 0.00 | -32.00K | -31.00K | -38.00K |
| Cash from Investing | 54.00K | -20.00K | -46.00K | -52.00K | -84.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -22.00K | -21.00K | -20.00K | -21.00K | -22.00K |
| Issuance of Common Stock | 1.01M | 1.60M | 1.97M | 1.97M | 1.56M |
| Repurchase of Common Stock | -123.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.84M | 1.85M | 2.07M | 2.07M | 1.38M |
| Cash from Financing | 2.70M | 3.42M | 4.01M | 4.01M | 2.92M |
| Foreign Exchange rate Adjustments | -56.00K | 17.00K | -48.00K | 37.00K | 9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.12M | 1.03M | 1.82M | 506.00K | -1.06M |